Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RG.. please prove me wrong soon...

Thanks for your comments and same to you. I wasn't necessariy disagreeing with you. Just trying to point out a different perspective. Mainly, as a shareholder, I think it is important to keep the pressures and expectations on our management and BOD very high, without giving them opportunities to excuse their failures, as there is almost always a way to make lemons out of lemonade. In fact, the capitalist world is FULL of such examples, and there will ALWAYS be obstacles both large and small to blame.

From an investor's perspective, I definitely support the new direction and am willing to forgive the past errors PROVIDED they don't keep continuing them. (Unfortunately, I don't see them living up to that condition based on Leckrone's SHM antics, the PDS Management commitee imbalance, etc.).

I also think that while he's done a pretty good job at telling that new direction story, RG could jazz it up a bit more and attract more attention to it. Perhaps it's still premature to do that and based on his seeming M.O. as a no-nonsense manager, he may be intent on letting the results do the talking, which is a good thing. Hard to complain with that approach, EXCEPT to say that while I personally like that approach generally, when he's tied so much of the future to M&A based primarily on using stock for deals, he HAS to pay attention to the pps as well, and "service" it also in other proactive and investor friendly ways, IMO. So even if he is only "Half a CEO", he needs to play up his half as much as possible to energize new investors to take the plunge. Without them, regardless of any good news, there will be no pps appreciation.

Share
New Message
Please login to post a reply